Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fearon

Showing results (81-90 of 239) with videos related to

Pageof 24
Sort By:
Trends in Molecular Medicine|April 12, 2017
Connecting the Metabolic and Immune Responses to CancerThomas R Flint, Douglas T Fearon, Tobias Janowitz
Neuroscience Research|August 2, 2005
The proto-oncogene BCL-6 is expressed in olfactory sensory neuronsJoji M Otaki, Douglas T Fearon, Haruhiko Yamamoto
Rheumatology|January 1, 1975
The properdin pathway: mechanisms of complement activation and analogies to the classical pathwayD T Fearon, K F Austen, S Ruddy
Arthritis and Rheumatism|July 1, 1975
Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritisS Ruddy, D T Fearon, K F Austen
Springer Seminars in Immunopathology|January 1, 1994
Therapeutic uses of recombinant complement protein inhibitorsK R Kalli, P Hsu, D T Fearon
The Journal of Experimental Medicine|December 1, 1973
Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complementD T Fearon, K F Austen, S Ruddy
The Journal of Experimental Medicine|June 1, 1981
Membrane distribution and adsorptive endocytosis by C3b receptors on human polymorphonuclear leukocytesD T Fearon, I Kaneko, G G Thomson
Transplantation Proceedings|February 1, 1993
Effect of repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenograftsW Xia, D T Fearon, R L Kirkman
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1973
Serum proteins involved in decay and regeneration of cobra venom factor-dependent complement activationD T Fearon, K F Austen, S Ruddy
The Journal of Experimental Medicine|February 1, 1974
Properdin factor D: characterization of its active site and isolation of the precursor formD T Fearon, K F Austen, S Ruddy
Pageof 24

Showing results (81-90 of 239) with videos related to

Sort By:
Pageof 24
Trends in Molecular Medicine|April 12, 2017
Connecting the Metabolic and Immune Responses to CancerThomas R Flint, Douglas T Fearon, Tobias Janowitz
Neuroscience Research|August 2, 2005
The proto-oncogene BCL-6 is expressed in olfactory sensory neuronsJoji M Otaki, Douglas T Fearon, Haruhiko Yamamoto
Rheumatology|January 1, 1975
The properdin pathway: mechanisms of complement activation and analogies to the classical pathwayD T Fearon, K F Austen, S Ruddy
Arthritis and Rheumatism|July 1, 1975
Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritisS Ruddy, D T Fearon, K F Austen
Springer Seminars in Immunopathology|January 1, 1994
Therapeutic uses of recombinant complement protein inhibitorsK R Kalli, P Hsu, D T Fearon
The Journal of Experimental Medicine|December 1, 1973
Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complementD T Fearon, K F Austen, S Ruddy
The Journal of Experimental Medicine|June 1, 1981
Membrane distribution and adsorptive endocytosis by C3b receptors on human polymorphonuclear leukocytesD T Fearon, I Kaneko, G G Thomson
Transplantation Proceedings|February 1, 1993
Effect of repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenograftsW Xia, D T Fearon, R L Kirkman
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1973
Serum proteins involved in decay and regeneration of cobra venom factor-dependent complement activationD T Fearon, K F Austen, S Ruddy
The Journal of Experimental Medicine|February 1, 1974
Properdin factor D: characterization of its active site and isolation of the precursor formD T Fearon, K F Austen, S Ruddy
Pageof 24